摘要
目的比较宁波地区国家标准化代谢性疾病管理中心(National Metabolic Management Center,MMC)和常规住院模式对2型糖尿病患者的血糖管理效果。方法入选2018年3月至2020年1月在宁波市第一医院门诊就诊并纳入MMC管理的367例2型糖尿病患者为MMC组。按照年龄、性别、病程、基线的空腹血糖及糖化血红蛋白水平以1∶1匹配原则选取2018年3月至2020年1月在宁波市第一医院住院治疗的2型糖尿病患者为住院组。MMC组按照MMC标准对糖尿病患者进行诊疗,住院组采取三甲医院的常规住院诊疗模式。回顾性分析随访半年后两种管理模式对患者血糖水平的影响。结果随访半年后,MMC诊疗模式组和住院诊疗模式组管理前后空腹血糖、糖化血红蛋白、总胆固醇、甘油三酯、低密度脂蛋白胆固醇、丙氨酸转氨酶均较基线水平明显改善(P<0.05)。结论MMC对宁波地区2型糖尿病患者的糖化血红蛋白水平有较大改善作用,从8.32%下降至6.91%。与住院组相比,MMC组能够达到同等的血糖控制水平。
Objective To compare the effects of glycemic management between the National Metabolic Management Center(MMC)and routine hospitalization on patients with type 2 diabetes mellitus(T2DM).Methods Totally 367 patients with T2DM who were involved in the management of MMC and treated in Ningbo First Hospital's clinic from March,2018 to January,2020,were selected as MMC group.The hospitalized patients with T2DM)in Ningbo First Hospital were selected as hospitalization group from March,2018 to January,2020 according to 1∶1 matching principle based on age,gender,course,fasting blood grulose's basal level and hemoglobin A 1c's basal level.Patients in MMC group were treated according to MMC standards,while those in hospitalization group had routine treatment of three-A hospitals.After the follow-up of half a year,the effects of two kinds of management on patients glycemic level were analyzed retrospectively.Results After the follow-up of half a year,compared with the baseline,fasting blood glucose,hemoglobin A 1c,total cholesterol,triglyceride,low density lipoprotein cholesterol,alanine aminotransferase in both groups were significantly improved(P<0.05).Conclusion MMC has good effects on the improvement of hemoglobin A 1c level which decreased from 8.32%to 6.91%in the patients.Compared with the hospitalization group,MMC group can reach the same level of glucose control.
作者
王学鹏
周晔
徐斌
金庸
周人可
励丽
Wang Xuepeng;Zhou Ye;Xu Bin;Jin Yong;Zhou Renke;Li Li(School of Medicine,Ningbo University,Ningbo 315211,China;Department of Endocrinology,Ningbo First Hospital,Ningbo 315010,China)
出处
《临床荟萃》
CAS
2020年第11期992-996,共5页
Clinical Focus
关键词
糖尿病
2型
疾病管理
糖化血红蛋白
diabetes mellitus,type 2
disease management
hemoglobin A 1c